Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19

NCT04440007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid-19

Interventions

DRUG: Abivertinib
OTHER: Standard of Care

Sponsor

Sorrento Therapeutics, Inc.